申请人:Dana-Farber Cancer Institute, Inc.
                            
                            
                                公开号:EP2937345A2
                            
                            
                                公开(公告)日:2015-10-28
                            
                            
The present invention relates to novel compounds (II), (III) and (IV) which are able to modulate b-raf kinases, and the use of such compounds in the treatment of various diseases, disorders or conditions.
                            本发明涉及能够调节 b-raf 激酶的新型化合物 (II)、(III) 和 (IV),以及这类化合物在治疗各种疾病、失调或病症中的用途。